Advisor Group Holdings, Inc. Blueprint Medicines Corp Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 4,362 shares of BPMC stock, worth $420,845. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,362

Previous 11,593 62.37%

Holding current value

$420,845

Previous $1.25 Million 67.73%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$84.1 - $120.5 $608,127 - $871,335	-7,231 Reduced 62.37%	4,362 $403,000
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $942,005 - $1.2 Million	11,059 Added 2070.97%	11,593 $1.25 Million
Q1 2024 May 10, 2024	SELL	$73.17 - $99.79 $557,774 - $760,699	-7,623 Reduced 93.45%	534 $50,000
Q4 2023 Feb 12, 2024	BUY	$43.96 - $92.84 $239,274 - $505,328	5,443 Added 200.55%	8,157 $752,000
Q3 2023 Nov 13, 2023	BUY	$46.9 - $66.0 $4,127 - $5,808	88 Added 3.35%	2,714 $136,000
Q2 2023 Aug 10, 2023	BUY	$42.2 - $66.37 $5,528 - $8,694	131 Added 5.25%	2,626 $165,000
Q1 2023 May 12, 2023	SELL	$37.97 - $50.0 $33,375 - $43,950	-879 Reduced 26.05%	2,495 $112,000
Q4 2022 Feb 10, 2023	SELL	$41.06 - $66.48 $6,282 - $10,171	-153 Reduced 4.34%	3,374 $147,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $9,237 - $14,374	-185 Reduced 4.98%	3,527 $233,000
Q2 2022 Aug 10, 2022	BUY	$45.23 - $70.15 $31,118 - $48,263	688 Added 22.75%	3,712 $188,000
Q1 2022 May 04, 2022	SELL	$54.1 - $110.08 $25,643 - $52,177	-474 Reduced 13.55%	3,024 $193,000
Q3 2021 Nov 05, 2021	BUY	$80.98 - $109.47 $2,186 - $2,955	27 Added 0.78%	3,498 $360,000
Q2 2021 Aug 02, 2021	BUY	$82.78 - $101.0 $81,786 - $99,788	988 Added 39.79%	3,471 $303,000
Q1 2021 May 13, 2021	BUY	$90.71 - $108.28 $22,042 - $26,312	243 Added 10.85%	2,483 $242,000
Q4 2020 Feb 10, 2021	BUY	$92.08 - $124.48 $13,443 - $18,174	146 Added 6.97%	2,240 $252,000
Q3 2020 Nov 12, 2020	BUY	$66.45 - $92.7 $8,040 - $11,216	121 Added 6.13%	2,094 $193,000
Q2 2020 Aug 14, 2020	BUY	$57.09 - $79.27 $81,638 - $113,356	1,430 Added 263.35%	1,973 $154,000
Q1 2020 May 18, 2020	BUY	$48.11 - $82.22 $26,123 - $44,645	543 New	543 $32,000

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.76B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Blueprint Medicines Corp Transaction History